Tigecycline Market by Application 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Tigecycline Market
Tigecycline Market: by Application (Skin & Soft Tissue Infections, Complicated Intra-abdominal Infections, and Community-acquired Bacterial Infection); Target Bacteria Type (Gram Positive and Gram Negative) and Geography - Forecast(2018 - 2023)
Report Code : CMR 0247
Updated Date: 14 March, 2018  
7

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Tigecycline – Market Overview
2. Executive Summary
3. Tigecycline – Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Tigecycline – Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Tigecycline Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Tigecycline Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Suppliers/Distributors Analysis
6. Tigecycline Market – By Applications:
   6.1. Introduction
   6.2. Skin & Soft Tissue Infections,
   6.3. Complicated Intra-abdominal Infections and
   6.4. Community-acquired Bacterial Pneumonia
7. Tigecycline Market - By Target Bacteria Type:
   7.1. Introduction
   7.2. Gram Positive Bacteria and
   7.3. Gram Negative Bacteria
8. Tigecycline Market- By Geography:
   8.1. Introduction
   8.2. North America
      8.2.1. U.S.
      8.2.2. Canada
      8.2.3. Mexico
      8.2.4. Rest of North America
   8.3. Europe
      8.3.1. France
      8.3.2. Germany
      8.3.3. Italy
      8.3.4. Spain
      8.3.5. U.K
      8.3.6. Rest of Europe
   8.4. APAC
      8.4.1. Australia
      8.4.2. China
      8.4.3. India
      8.4.4. Japan
      8.4.5. Rest of APAC
   8.5. ROW
      8.5.1. Middle East & Africa
      8.5.2. South America
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
   10.1. Company 1
   10.2. Company 2
   10.3. Company 3
   10.4. Company 4
   10.5. Company 5
   10.6. Company 6
   10.7. Company 7
   10.8. Company 8
   10.9. Company 9
   10.10. Company 10
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Tigecycline is a broad spectrum glycylcycline type acting as a protein synthesis inhibitor. Tigecycline blocks the interaction of aminoacyl-tRNA with the A site of the ribosome by binding to the 30S ribosomal subunit of bacteria and thus exhibits bacteriostatic activity. Additionally, Tigecycline is shown to exhibit bactericidal activity against isolates of L. pneumophila and S. pneumoniae.

Tigecycline is used to treat a variety of bacterial infections and thus acts as an antibiotic. Tigecycline is a first glycylcycline type that is administered intravenously. The main reason for the discovery of Tigecycline is the rising rate of antibiotic resistance in a number of bacteria such as Acinetobacter baumannii, Staphylococcus aureus, and E. coli. Tigecycline is a tetracycline derivative antibiotic and thus its structural modifications have extended its therapeutic activity to include Gram-negative and Gram-positive bacteria, comprising those of multi-drug resistance. The increasing demand for Tigecycline as an antibiotic is expected to fuel the market growth over the forecast period.

Tigecycline is recommended by the European Society of Clinical Microbiology and Infection as a potential salvage therapy for complicated and severe refractory Clostridium difficile infection. Tigecycline also finds application in treatment of immune-compromised patients or patients having cancer. Even more, tigecycline have potential for use in acute myeloid leukemia. Tigecycline is prescribed at every 12 hours with slow intravenous infusion. Patients suffering with impaired liver function needs to be prescribed a lower dose of tigecycline. No adjustments are needed for patients suffering with impaired kidney function.

The global Tigecycline market is classified into applications as Skin & Soft-tissue Infections, Complicated Intra-abdominal Infections and Community-acquired Bacterial Pneumonia. In addition, the global Tigecycline market is further bifurcated on the basis of target bacteria type into Gram Positive Bacteria and Gram Negative Bacteria.

Lastly, the global tigecycline market is bifurcated by regions as North America, Asia Pacific (APAC), Europe and Rest of the World (RoW). Presently, the global tigecycline market is dominated by Asia-Pacific region primarily due to a significant adoption of tigecycline as an antibiotic in pharmaceuticals industry. The APC region is also expected to continue its dominance in the market during the forecast period. The European and North American regions are also analyzed to witness a healthy growth rate in the global tigecycline market during the forecast period.

Tigecycline Market

Sample Companies Profiled in this Report are:
  • Pfizer Inc. (U.S.)
  • Hisun Pharma (U.S.)
  • Hansoh Pharma (China)
  • Jiagsu Aosaikang Pharmaceutical Co. Ltd. (China)
  • Abbott Laboratories (U.S.)
  • 10+.
List of Tables

Table 1 Tigecycline Market Overview 2017-2023
Table 2 Tigecycline Market Leader Analysis 2017-2018 (US$)
Table 3 Tigecycline MarketProduct Analysis 2017-2018 (US$)
Table 4 Tigecycline MarketEnd User Analysis 2017-2018 (US$)
Table 5 Tigecycline MarketPatent Analysis 2013-2018* (US$)
Table 6 Tigecycline MarketFinancial Analysis 2017-2018 (US$)
Table 7 Tigecycline Market Driver Analysis 2017-2018 (US$)
Table 8 Tigecycline MarketChallenges Analysis 2017-2018 (US$)
Table 9 Tigecycline MarketConstraint Analysis 2017-2018 (US$)
Table 10 Tigecycline Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11 Tigecycline Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12 Tigecycline Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13 Tigecycline Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14 Tigecycline Market Degree of Competition Analysis 2017-2018 (US$)
Table 15 Tigecycline MarketValue Chain Analysis 2017-2018 (US$)
Table 16 Tigecycline MarketPricing Analysis 2018-2023 (US$)
Table 17 Tigecycline MarketOpportunities Analysis 2018-2023 (US$)
Table 18 Tigecycline MarketProduct Life Cycle Analysis 2018-2023 (US$)
Table 19 Tigecycline MarketSupplier Analysis 2017-2018 (US$)
Table 20 Tigecycline MarketDistributor Analysis 2017-2018 (US$)
Table 21 Tigecycline Market Trend Analysis 2017-2018 (US$)
Table 22 Tigecycline Market Size 2017 (US$)
Table 23 Tigecycline Market Forecast Analysis 2018-2023 (US$)
Table 24 Tigecycline Market Sales Forecast Analysis 2018-2023 (Units)
Table 25 Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 26 Tigecycline MarketBy Application, Revenue & Volume,By Skin & Soft Tissue Infections,, 2018-2023 ($)
Table 27 Tigecycline MarketBy Application, Revenue & Volume,By Complicated Intra-abdominal Infections and, 2018-2023 ($)
Table 28 Tigecycline MarketBy Application, Revenue & Volume,By Community-acquired Bacterial Pneumonia, 2018-2023 ($)
Table 29 Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 30 Tigecycline MarketBy Target Bacteria Type, Revenue & Volume,By Gram Positive Bacteria and, 2018-2023 ($)
Table 31 Tigecycline MarketBy Target Bacteria Type, Revenue & Volume,By Gram Negative Bacteria, 2018-2023 ($)
Table 32 North America Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 33 North America Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 34 South america Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 35 South america Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 36 Europe Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 37 Europe Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 38 APAC Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 39 APAC Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 40 Middle East & Africa Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 41 Middle East & Africa Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 42 Russia Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 43 Russia Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 44 Israel Tigecycline Market, Revenue & Volume,By Application, 2018-2023 ($)
Table 45 Israel Tigecycline Market, Revenue & Volume,By Target Bacteria Type, 2018-2023 ($)
Table 46 Top Companies 2017 (US$)Tigecycline Market, Revenue & Volume,,
Table 47 Product Launch 2017-2018Tigecycline Market, Revenue & Volume,,
Table 48 Mergers & Acquistions 2017-2018Tigecycline Market, Revenue & Volume,,


List of Figures

Figure 1 Overview of Tigecycline Market 2017-2023
Figure 2 Market Share Analysis for Tigecycline Market 2017 (US$)
Figure 3 Product Comparison in Tigecycline Market 2017-2018 (US$)
Figure 4 End User Profile for Tigecycline Market 2017-2018 (US$)
Figure 5 Patent Application and Grant in Tigecycline Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Tigecycline Market 2017-2018 (US$)
Figure 7 Market Entry Strategy in Tigecycline Market 2017-2018
Figure 8 Ecosystem Analysis in Tigecycline Market2017
Figure 9 Average Selling Price in Tigecycline Market 2017-2023
Figure 10 Top Opportunites in Tigecycline Market 2017-2018
Figure 11 Market Life Cycle Analysis in Tigecycline MarketMarket Life Cycle Analysis in 3D Printing
Figure 12 GlobalBy ApplicationTigecycline Market Revenue, 2018-2023 ($)
Figure 13 GlobalBy Target Bacteria TypeTigecycline Market Revenue, 2018-2023 ($)
Figure 14 Global Tigecycline Market - By Geography
Figure 15 Global Tigecycline Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16 Global Tigecycline Market CAGR, By Geography, 2018-2023 (%)
Figure 17 North America Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 18 US Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 19 US GDP and Population, 2017-2018 ($)
Figure 20 US GDP – Composition of 2017, By Sector of Origin
Figure 21 US Export and Import Value & Volume, 2017-2018 ($)
Figure 22 Canada Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 23 Canada GDP and Population, 2017-2018 ($)
Figure 24 Canada GDP – Composition of 2017, By Sector of Origin
Figure 25 Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26 Mexico Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 27 Mexico GDP and Population, 2017-2018 ($)
Figure 28 Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29 Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30 South America Tigecycline MarketSouth America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31 Brazil Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 32 Brazil GDP and Population, 2017-2018 ($)
Figure 33 Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34 Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35 Venezuela Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 36 Venezuela GDP and Population, 2017-2018 ($)
Figure 37 Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38 Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39 Argentina Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 40 Argentina GDP and Population, 2017-2018 ($)
Figure 41 Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42 Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43 Ecuador Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 44 Ecuador GDP and Population, 2017-2018 ($)
Figure 45 Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46 Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47 Peru Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 48 Peru GDP and Population, 2017-2018 ($)
Figure 49 Peru GDP – Composition of 2017, By Sector of Origin
Figure 50 Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51 Colombia Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 52 Colombia GDP and Population, 2017-2018 ($)
Figure 53 Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54 Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55 Costa Rica Tigecycline MarketCosta Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56 Costa Rica GDP and Population, 2017-2018 ($)
Figure 57 Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58 Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59 Europe Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 60 U.K Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 61 U.K GDP and Population, 2017-2018 ($)
Figure 62 U.K GDP – Composition of 2017, By Sector of Origin
Figure 63 U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64 Germany Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 65 Germany GDP and Population, 2017-2018 ($)
Figure 66 Germany GDP – Composition of 2017, By Sector of Origin
Figure 67 Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68 Italy Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 69 Italy GDP and Population, 2017-2018 ($)
Figure 70 Italy GDP – Composition of 2017, By Sector of Origin
Figure 71 Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72 France Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 73 France GDP and Population, 2017-2018 ($)
Figure 74 France GDP – Composition of 2017, By Sector of Origin
Figure 75 France Export and Import Value & Volume, 2017-2018 ($)
Figure 76 Netherlands Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 77 Netherlands GDP and Population, 2017-2018 ($)
Figure 78 Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79 Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80 Belgium Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 81 Belgium GDP and Population, 2017-2018 ($)
Figure 82 Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83 Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84 Spain Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 85 Spain GDP and Population, 2017-2018 ($)
Figure 86 Spain GDP – Composition of 2017, By Sector of Origin
Figure 87 Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88 Denmark Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 89 Denmark GDP and Population, 2017-2018 ($)
Figure 90 Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91 Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92 APAC Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 93 China Tigecycline MarketValue & Volume, 2018-2023
Figure 94 China GDP and Population, 2017-2018 ($)
Figure 95 China GDP – Composition of 2017, By Sector of Origin
Figure 96 China Export and Import Value & Volume, 2017-2018 ($)Tigecycline MarketChina Export and Import Value & Volume, 2017-2018 ($)
Figure 97 Australia Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 98 Australia GDP and Population, 2017-2018 ($)
Figure 99 Australia GDP – Composition of 2017, By Sector of Origin
Figure 100 Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101 South Korea Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 102 South Korea GDP and Population, 2017-2018 ($)
Figure 103 South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104 South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105 India Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 106 India GDP and Population, 2017-2018 ($)
Figure 107 India GDP – Composition of 2017, By Sector of Origin
Figure 108 India Export and Import Value & Volume, 2017-2018 ($)
Figure 109 Taiwan Tigecycline MarketTaiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110 Taiwan GDP and Population, 2017-2018 ($)
Figure 111 Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112 Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113 Malaysia Tigecycline MarketMalaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114 Malaysia GDP and Population, 2017-2018 ($)
Figure 115 Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116 Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117 Hong Kong Tigecycline MarketHong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118 Hong Kong GDP and Population, 2017-2018 ($)
Figure 119 Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120 Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121 Middle East & Africa Tigecycline MarketMiddle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122 Russia Tigecycline MarketRussia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123 Russia GDP and Population, 2017-2018 ($)
Figure 124 Russia GDP – Composition of 2017, By Sector of Origin
Figure 125 Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126 Israel Tigecycline Market Value & Volume, 2018-2023 ($)
Figure 127 Israel GDP and Population, 2017-2018 ($)
Figure 128 Israel GDP – Composition of 2017, By Sector of Origin
Figure 129 Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130 Entropy Share, By Strategies, 2017-2018* (%)Tigecycline Market
Figure 131 Developments, 2017-2018*Tigecycline Market
Figure 132 Company 1 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 133 Company 1 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134 Company 1 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 135 Company 2 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 136 Company 2 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137 Company 2 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 138 Company 3Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 139 Company 3Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140 Company 3Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 141 Company 4 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 142 Company 4 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143 Company 4 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 144 Company 5 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 145 Company 5 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146 Company 5 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 147 Company 6 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 148 Company 6 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149 Company 6 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 150 Company 7 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 151 Company 7 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152 Company 7 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 153 Company 8 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 154 Company 8 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155 Company 8 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 156 Company 9 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 157 Company 9 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158 Company 9 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 159 Company 10 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 160 Company 10 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161 Company 10 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 162 Company 11 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 163 Company 11 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164 Company 11 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 165 Company 12 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 166 Company 12 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167 Company 12 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 168 Company 13Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 169 Company 13Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170 Company 13Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 171 Company 14 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 172 Company 14 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173 Company 14 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Figure 174 Company 15 Tigecycline Market Net Revenue, By Years, 2017-2018* ($)
Figure 175 Company 15 Tigecycline Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176 Company 15 Tigecycline Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll